Kerry Donegan, MD
Orthopaedic Surgery · Grapevine, TXNPI 1972509412
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,912 of the $4,359 with a category attached, or 89.7%. Pylant Medical accounts for 89.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $1,948 and has fallen 99.3% since, to $13 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in TX, where the typical reported total is $4,671.
Across 16 payments — averaging $272.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$4K
- Johnson & Johnson$194
- Medical Device Business Services, Inc.$136
- Heron Therapeutics, Inc.$92
- Pacira Pharmaceuticals Incorporated$25
What the payments were for
- Food & beverage$44810%
- Education$3,91290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 4 | $3,912 |
| Johnson & Johnson(2 entities) | 4 | $194 |
| Medical Device Business Services, Inc. | 4 | $136 |
| Heron Therapeutics, Inc. | 3 | $92 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Velys$166
How this compares
$4,359 in reported general payments places this provider in the 45th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 69 | $1,054 |
| Meloxicam | 280 | $627 |
| Oxycodone Hcl | 87 | $540 |
| Tramadol Hcl | 53 | $233 |
| Methylprednisolone | 34 | $206 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $176 |
| Amoxicillin | 19 | $26 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Grapevine
- Michael KhazzamGrapevine$284K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.